Stock Chart

KOD

$24.11 +5.88%
Score: 49.9 HOLD
LEAPs: SELL $32
i
LEAPs Option Signal

Type: SELL wallstreet
Strike: $32
Premium: $9.60
Expiry: Dec 18, 2026
Target: $31
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
30D Target: $19.17 - $27.85 STRONG_UPTREND
i
30D Trendline Target

This is a PROJECTED price range based on extrapolating the current trendline slope forward 30 days.

How it works:
• Draws support and resistance trendlines
• Calculates slope (rate of change)
• Projects lines to 30 days future

Signals:
● STRONG_UPTREND: Steep rise
● UPTREND: Moderate rise
● SIDEWAYS: Flat/Mixed
● DOWNTREND: Falling

⚠️ Not a prediction. Shows trend projection only.

R-squared: 0.86
Vol: 0.93x (vs SPY: 0.9x | vs QQQ: 1.0x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About KOD - Kodiak Sciences Inc Common Stock

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

Key Statistics

Market Cap $1B

This KOD stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track KOD's price movements with trendlines, gamma walls, and key support/resistance levels.